CXCL3 promotes liver cancer progression by modulating the tumor microenvironment via the PI3K/AKT/mTOR pathway
PLOS One · 2025
DOI: 10.1371/journal.pone.0334639 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Basic Medical College, Jiamusi University, Jiamusi, Heilongjiang, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Liver Neoplasms, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Cultivation Project of the Natural Science Foundation of Heilongjiang, China, Youth Program of Open Research Project in State Key Laboratory of Neurology and Oncology Drug Development, China, National Fund Incubation Project of Jiamusi University, China.
Abstract (Originalsprache)
CXCL3, a member of the CXC chemokine family, has been increasingly implicated in the progression of various cancers, including hepatocellular carcinoma, due to its role in immune and inflammatory responses within the tumor microenvironment. This study aimed to investigate the expression and function of CXCL3 in liver cancer and to elucidate its underlying mechanisms. A combination of bioinformatics analysis, ELISA, RT-qPCR, immunohistochemistry, in vitro cell assays, and in vivo nude mouse models was employed to assess CXCL3 expression and function. The results showed that CXCL3 was significantly upregulated in hepatocellular carcinoma tissues and associated with reduced overall survival in patients. It promoted the proliferation, colony formation, and migration of liver cancer cells (Bel-7402, HepG2, and SMMC-7721) via exogenous, autocrine, and paracrine mechanisms, and recruited tumor-associated macrophages, neutrophils, and fibroblasts into the tumor microenvironment. Mechanistically, CXCL3 activated the PI3K/AKT/mTOR pathway by upregulating PI3K, p-PI3K, AKT, p-AKT, mTOR, and p-mTOR, while the mTOR inhibitor Torin 1 reversed these effects. Gene set enrichment analysis showed enrichment in immune-related pathways, including Toll-like receptor and chemokine signaling. In vivo, CXCL3 overexpression significantly promoted tumor growth in nude mice. These findings suggest CXCL3 facilitates liver cancer progression through tumor microenvironment modulation and PI3K/AKT/mTOR pathway activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Basic Medical College, Jiamusi University, Jiamusi, Heilongjiang, China.
- Key laboratory of Microecology-immune Regulatory Network and Related Diseases School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang Province, China.
- Department of Surgery, First College of Medicine, Jiamusi University, Jiamusi, Heilongjiang, China.
- School of Public Health, Jiamusi University, Jiamusi, Heilongjiang, China.
- State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, Jiangsu, China.
ORCID-Profile: Weiqun Wang
Förderung
- Joint Cultivation Project of the Natural Science Foundation of Heilongjiang, China
- Youth Program of Open Research Project in State Key Laboratory of Neurology and Oncology Drug Development, China
- National Fund Incubation Project of Jiamusi University, China
- Basic Scientific Research Expenses Scientific Research Projects of Universities in Heilongjiang province, China
- East Pole team project of Jiamusi University, Heilongjiang, China
Zitieren
APA
Li, Y., Liu, T., Cai, Z., Peng, C., He, Z., Liang, L., Han, B., Bi, R., Liu, L., & Wang, W. (2025). CXCL3 promotes liver cancer progression by modulating the tumor microenvironment via the PI3K/AKT/mTOR pathway. PLOS One. https://doi.org/10.1371/journal.pone.0334639
Vancouver
Li Y, Liu T, Cai Z, Peng C, He Z, Liang L, et al. CXCL3 promotes liver cancer progression by modulating the tumor microenvironment via the PI3K/AKT/mTOR pathway. PLOS One. 2025. doi:10.1371/journal.pone.0334639
BibTeX
@article{Li2025,
author = {Li, Yue and Liu, Tao and Cai, Ziteng and Peng, Chaonan and He, Zhilei and Liang, Lichun and Han, Bo and Bi, Ran and Liu, Lei and Wang, Weiqun},
title = {CXCL3 promotes liver cancer progression by modulating the tumor microenvironment via the PI3K/AKT/mTOR pathway},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0334639}
}
EUVIMED